Literature DB >> 14613342

Indicators of preventable drug-related morbidity in older adults 2. Use within a managed care organization.

Neil J Mackinnon1, Charles D Hepler.   

Abstract

OBJECTIVE: To determine the incidence of preventable drug-related morbidity (PDRM) in older adults in a provider-sponsored network and identify risk factors for PDRM.
METHODS: The study was based on a retrospective review of an integrated health care database, using 52 newly developed clinical indicators of PDRM. The incidence of PDRM was determined by identifying individuals in the database who matched an outcome and pattern of care associated with an indicator. Risk factors were determined through a forward inclusion logistic regression model. The subjects in this study were 3,365 older adults enrolled in a hospital-based health care system in Florida in 1997. The principal outcome measure was identification of individuals who matched a PDRM indicator and risk factors for PDRM.
RESULTS: Ninety-seven enrollees who matched one or more of 52 PDRM indicators were found in 3,365 older adults, for an overall incidence rate of 28.8 per 1000. The top 5 indicators of PDRM were responsible for 46.8% of all PDRMs found. Regression analysis identified 5 risk factors: 4 or more recorded diagnoses, 4 or more prescribers, 6 or more prescription medications, antihypertensive drug use, and male gender.
CONCLUSION: This study demonstrated that clinical indicators can be used in a managed care organization to identify seniors who have experienced a PDRM. The risk model should better prepare managed care organizations to proactively identify patients at risk for PDRM and to optimize medication use in older adults.

Entities:  

Mesh:

Year:  2003        PMID: 14613342     DOI: 10.18553/jmcp.2003.9.2.134

Source DB:  PubMed          Journal:  J Manag Care Pharm        ISSN: 1083-4087


  8 in total

1.  Preventable drug-related morbidity in community pharmacy: commentary on the implications for practice and policy of a novel intervention.

Authors:  Mara Pereira Guerreiro; Ana Paula Martins; Judith Anne Cantrill
Journal:  Int J Clin Pharm       Date:  2012-07-10

Review 2.  Preventability of drug-related harms - part I: a systematic review.

Authors:  Robin E Ferner; Jeffrey K Aronson
Journal:  Drug Saf       Date:  2010-11-01       Impact factor: 5.606

Review 3.  Integrating performance assessment, maintenance of competence, and continuing professional development of community pharmacists.

Authors:  Nancy E Winslade; Robyn M Tamblyn; Laurel K Taylor; Lambert W T Schuwirth; Cees P M Van der Vleuten
Journal:  Am J Pharm Educ       Date:  2007-02-15       Impact factor: 2.047

4.  The development and evaluation of an integrated electronic prescribing and drug management system for primary care.

Authors:  Robyn Tamblyn; Allen Huang; Yuko Kawasumi; Gillian Bartlett; Roland Grad; André Jacques; Martin Dawes; Michal Abrahamowicz; Robert Perreault; Laurel Taylor; Nancy Winslade; Lise Poissant; Alain Pinsonneault
Journal:  J Am Med Inform Assoc       Date:  2005-12-15       Impact factor: 4.497

Review 5.  Preventable drug-related morbidity in community pharmacy: development and piloting of a complex intervention.

Authors:  Mara Pereira Guerreiro; Ana Paula Martins; Judith Anne Cantrill
Journal:  Int J Clin Pharm       Date:  2012-04-17

6.  Indicators for preventable drug related morbidity: application in primary care.

Authors:  C J Morris; S Rodgers; V S Hammersley; A J Avery; J A Cantrill
Journal:  Qual Saf Health Care       Date:  2004-06

7.  Recognition and management of chronic kidney disease in an elderly ambulatory population.

Authors:  Michael B Rothberg; Eileen D Kehoe; Abbie L Courtemanche; Thabo Kenosi; Penelope S Pekow; Maura J Brennan; Jeffrey G Mulhern; Gregory L Braden
Journal:  J Gen Intern Med       Date:  2008-04-29       Impact factor: 5.128

8.  Development of evidence-based Australian medication-related indicators of potentially preventable hospitalisations: a modified RAND appropriateness method.

Authors:  Gillian E Caughey; Lisa M Kalisch Ellett; Te Ying Wong
Journal:  BMJ Open       Date:  2014-04-28       Impact factor: 2.692

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.